ELISOR
Pravastatin
CAS: 81093-37-0
Molecular Formula: C23H36O7
ELISOR - Names and Identifiers
| Name | Pravastatin |
| Synonyms | ELISOR KOPOSTAT MEVALOTIN PRAVACHOL PRAVASTATIN Pravastatin PRAVASELECT EPTASTATIN SODIUM (3R,5S)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid 1-naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8-[[(2S)-2-methyl-1-oxobutyl]oxy]-, (betaR,deltaR,1S,2S,6S,8S,8aR)- (3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid (BETA R,DELTA R,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-1-NAPHTHALENEHEPTANOIC ACID MONOSODIUM SALT |
| CAS | 81093-37-0 |
| InChI | InChI=1/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16?,17+,18+,19-,20-,22-/m0/s1 |
ELISOR - Physico-chemical Properties
| Molecular Formula | C23H36O7 |
| Molar Mass | 424.53 |
| Density | 1.21±0.1 g/cm3(Predicted) |
| Melting Point | 171.2-173°C |
| Boling Point | 634.5±55.0 °C(Predicted) |
| Flash Point | 213.2°C |
| Solubility | H2O: 19mg/mL |
| Vapor Presure | 9.15E-19mmHg at 25°C |
| Appearance | powder |
| Color | white |
| pKa | 4.31±0.10(Predicted) |
| Storage Condition | Sealed in dry,Room Temperature |
| Refractive Index | 1.554 |
| Physical and Chemical Properties | White to yellowish white powder or crystalline powder, odorless, bitter. UV absorption maximum (methanol):230,237,245nm. Lactone: C23H34O6. Colorless Flake Crystal, melting point 138-142 ℃. [Α] D 22 194.0 °(C = 0.51, methanol). UV absorption maximum (methanol):230,237,245nm. |
| Use | Used as hypolipidemic, cholesterol drugs |
ELISOR - Risk and Safety
| Risk Codes | R11 - Highly Flammable R34 - Causes burns |
| Safety Description | S16 - Keep away from sources of ignition. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
| WGK Germany | 2 |
| RTECS | QJ7185000 |
ELISOR - Nature
Open Data Verified Data
white to yellowish white powder or crystalline powder, odorless, bitter. UV absorption maximum (methanol):230, 237, 245nm.
Last Update：2024-01-02 23:10:35
ELISOR - Preparation Method
Open Data Verified Data
The hydroxy compound, pravastatin, was biotransformed by ML-236B (competitive).
Last Update：2022-01-01 09:11:00
ELISOR - Use
Open Data Verified Data
Japan's three companies Development, 1 9 8 9 listed in March. HMG-CoA reductase inhibitors have a reducing effect on various hyperlipidemia models. For hyperlipidemia, familial hypercholesterolemia, etc.
Last Update：2022-01-01 09:11:00
Supplier List
Spot supply
Product Name: Pravastatin Monomer Visit Supplier Webpage Request for quotationCAS: 81093-37-0
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
Spot supply
Product Name: Pravastatin Monomer Visit Supplier Webpage Request for quotationCAS: 81093-37-0
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052
Wechat: 15671228036
View History